Evidence is currently lacking regarding the outcomes of kidneys undergoing hypothermic machine perfusion (HMP) in patients in the United Kingdom. Using the National Health Service Blood and Transplant database, the authors compared outcomes for recipients of single-organ donation after circulatory death (DCD) kidneys preserved with HMP with those preserved using only static cold storage (SCS). Between 2007 and 2015, HMP was used in 19.1% (864/4,529) of kidneys. Rates of delayed graft function (DGF) were significantly lower in organs preserved with HMP than for organs preserved with SCS (34.2% vs 42.0%, P < .001), despite a slightly longer cold ischemic time (median: 14.8 vs 14.1 hours, P < .001). Multivariable analysis found the effect of preservation modality to remain significant, with HMP organs having a significantly lower rate of DGF (odds ratio 0.65, 95% confidence interval 0.53-0.80, P < .001) and significantly shorter times to DGF resolution (average: 6.1 vs 7.4 days, P = .003) than SCS organs. The patient (P = .313) and graft (P = .263) survival rates were similar in the 2 preservation groups. HMP was associated with a marginal functional benefit in 1-year creatinine values (P = .044), with adjusted averages of 1.36 mg/dL (HMP) versus 1.40 mg/dL (SCS). This study supports the use of HMP and aids decisionmaking over its instigation, which may improve short-term patient outcomes.
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PATEL ET AL. HMP in the United Kingdom, particularly where the opportunity to commence HMP at the time of donation rarely exists. Hence, clinicians are required to decide whether HMP should be commenced only after the kidney has arrived at their units in SCS conditions. Against this background, the aim of this study was to review current practices and outcomes for DCD kidneys in an attempt to strengthen future decision-making regarding commencing HMP when DCD kidneys arrive at the recipient unit. Creatinine was only recorded for those patients still alive and being followed up at the time.
| METHODS

| Study population
| Outcome measures
Primary outcome measures were rates of DGF and graft survival (death censored). DGF was defined as the need for dialysis in the first week after renal transplantation. Secondary outcome measures were time to resolution of DGF; serum creatinine values at 1, 3, and 5 years; and patient survival.
| Statistical methods
Initially, univariable analyses were performed to compare a range of factors and outcomes between the HMP and SCS groups. Ordinal and non-normally distributed variables were compared between groups by using Mann-Whitney tests, while nominal variables were compared by using the Fisher exact test where there were 2 categories and χ 2 tests
otherwise. Patient and graft survival rates were compared by using Kaplan-Meier curves with log-rank tests. Patient survival was considered only for patients receiving their first graft. Creatinine levels and the time to resolution of DGF both followed skewed distributions and so were log 10 -transformed before analysis. The resulting values were compared between groups by using independent-samples t-tests and summarized by using geometric means and 95% confidence intervals (CIs).
Multivariable analyses were then performed to assess the differences between the HMP and SCS groups, after accounting for the effects of potentially confounding factors. This analysis was based on binary logistic regression models for dichotomous outcomes, general linear models of log 10 -transformed data for continuous outcomes, and Cox regression for the survival outcomes. Before the analysis, the goodness of fit of each continuous factor was assessed, either , P = .006) and were less likely to be from donors with hypertension (24.2% vs 28.1%, P = .028). In addition, HMP use was found to differ by both donor and recipient ethnicity (both P < .001) and dialysis modality at time of transplantation (P = .008).
| RESULTS
| Demographics
HMP kidneys had a longer CIT (median 14.8 vs 14.1 hours, P < .001),
and reperfusion more commonly took place during the daytime (P < .001). HMP use was also found to be in decline during the study period, from being used in 25.6% of the transplantations in 2007-2010 to 14 .4% of transplantations in 2014-2015 (P < .001) ( Table 2) .
Patient outcomes were then compared between the HMP and SCS groups. The results of these analyses are summarized in Table 3, while the full multivariable models are reported in Tables S1-S5. After adjustment for confounding factors (Tables S1 and S2) , multivariable analysis found the effect of preservation modality to remain significant, with HMP organs having a significantly lower rate of DGF (OR 0.65, 95% CI 0.53-0.80, P < .001) and significantly shorter times to DGF resolution (17.7% shorter, 95% CI 6.2%-27.8%, adjusted average: 6.1 vs 7.4 days, P = .003) than SCS organs.
| Delayed graft function
| Patient and graft survival
There was no evidence of a significant association between preservation modality (HMP or SCS) and either patient survival (P = .813) Ordinal factors were compared between the groups by using MannWhitney tests.
T A B L E 1 (Continued) (Continues) or graft survival (death censored) (P = .452, Figure 1 ) on univariable analysis. These relationships remained nonsignificant after adjustment for confounding factors on multivariable analysis, with P = .313 and P = .263, respectively (Table S3-S4) .
| Creatinine
Creatinine levels at follow-up were available at 12, 36, and 60 months in 87%, 59%, and 35% of the cohort, respectively. On univariable analysis, there was a tendency for creatinine levels to be lower in the HMP group compared to the SCS group, at 12 months (geometric mean: 1.36 vs 1.40 mg/dL, P = .055), 36 months (1.35 vs 1.40 mg/ dL, P = .072), and 60 months (1.35 vs 1.40 mg/dL, P = .133), although none of these comparisons reached statistical significance.
However, after accounting for confounding factors in a multivariable analysis (Table S5 ), a significant difference in 12-month creatinine levels was detected (P = .044), with levels found to be 2.8% lower in organs preserved using HMP compared with the use of SCS (95% CI 0.1%-5.3%). Evaluating the model at the midpoints of the factors accounted for produced adjusted average 12-month creatinine levels of 1.36 and 1.40 mg/dL for HMP and SCS kidneys, respectively.
| Association between DGF and HMP by CIT
A set of analyses were then performed to assess whether the previously observed association between HMP and reduced rates of DGF varied with CIT. In a binary logistic regression model with CIT, the preservation modality and an interaction term as factors, the interaction was close to reaching statistical significance (P = .087). For this reason, separate multivariable analyses of DGF were produced for the HMP and SCS subgroups, to further assess the impact of CIT (Table S6 ).
This found a tendency for the rate of DGF to increase with CIT in the SCS group (OR per 10 hours: 1.08, 95% CI 0.91-1.28, P = .366) but to decrease with CIT where HMP was used (OR per 10 hours: 0.76, 95%
CI 0.52-1.10, P = .142), although neither of these effects reached statistical significance. This relationship is depicted in Figure 2 . Ordinal factors were compared between the groups by using Mann-Whitney tests. b The ungrouped values were compared by using Mann-Whitney tests.
T A B L E 2 Transplant and mismatch factors by hypothermic machine perfusion (HMP) vs static cold storage (SCS)
| Association between DGF rates and HMP use by centers
A subgroup analysis was performed to assess whether the reduction in DGF rates with HMP varied by the HMP use strategy of the transplanting center. The 23 transplant centers were divided into 3 groups: those that used HMP in less than 5%, 5% to 20%, and more than 20% of cases (Table 4) . A binary logistic regression model was then produced to assess whether the effect of HMP on DGF differed between these groups. This found no significant interaction between these factors (P = .081), although there was a tendency for HMP to be more effective in reducing rates of DGF in centers where it was used more frequently (ie, in >20% of cases, OR 0.66, P < .001)
than for the intermediate-use group (ie, in 5-20% of cases, OR 1.08, P = .697). Table S1 . Time to DGF resolution: Results are reported as percentage differences between groups from general linear models of log 10 -transformed data. The full multivariable analysis is reproduced in Table S2 . Survival: Results are reported as hazard ratios from Cox regression models. Analysis of patient survival only includes those patients receiving their first graft. The full multivariable analyses are reproduced in Tables S3 and S4 . Creatinine: Results are reported as percentage differences between groups from general linear models of log 10 -transformed data. The full multivariable analysis is reproduced in Table S5 .
| DISCUSSION
F I G U R E 1 Kaplan-Meier curve of graft survival by preservation modality F I G U R E 2 Associations between cold ischemia time (CIT) and delayed graft function (DGF) in the hypothermic machine perfusion (HMP) and static cold storage (SCS) cohorts. The points represent DGF rates and 95% confidence intervals within 4 hourly intervals of CIT, plotted at the midpoints of the interval. Trend lines are from univariable binary logistic regression models within the SCS and HMP subgroups, with CIT as a covariate strengths of a population-based analysis. The absolute risk reduction in DGF in this study (7.8%) was greater than that in the previously reported machine preservation trial 1 (5.7%), where HMP was commenced at the retrieval center. Similar to previous studies, 1,12 our results demonstrate a reduction in the duration of DGF for kidneys undergoing HMP, further reaffirming the short-term benefits of HMP, even following an initial storage period in SCS conditions. Yet, while lower rates of DGF after renal transplantation may infer improved graft survival in general, 13 our data did not show the same benefit for HMP kidneys. In our cohort, as with previous studies, 2,3 no longerterm benefit was observed for kidneys undergoing a period of HMP. that there appear to be no short-term adverse effects of increasing CIT with a period of HMP. This would appear to support the practice of overnight perfusion of DCD kidneys by using HMP as a bridging therapy, provided total CIT is projected to be less than 24 hours, as previously described in our unit. 15 Furthermore, we found that HMP kidneys had a slightly longer CIT and were more likely to transplanted during daylight hours. This finding suggests, at least in some centers, The presence of multiple renal arteries has been associated with higher rates of DGF 16 and may have affected selection for HMP, given that organ anatomy changed allocation to preservation modality in the machine preservation trial. 1 Pump perfusion parameters, such as renal resistance, may be predictive of posttransplantation outcome 17 thereby leading to discard of organs deemed worse quality although, conversely, the same characteristics may provide reassurance, leading to lower discard rates than those assessed by transplant surgeon alone.
18
This large, well-populated data set does, however, enable robust statistical analysis. As part of this review, it was surprising to find that despite the demonstrable benefits of HMP, its use in the United Kingdom declined during the study period. The reasons for this are not clear and contrast with results of an analysis of transplant registry data in the United States that describes HMP being used in two-thirds of DCD kidneys. 19 Nevertheless, the UK data may reflect a waning national interest, perhaps resulting from a lack of clear overall evidence supporting HMP use, combined with a lack of explicit guidance regarding specific situations in which HMP is beneficial.
However, in an era of transplantation where DCD kidneys account for between one-fourth and one-third of all single-organ kidney transplants in the United Kingdom, this study, using real-world data, supports the use of HMP, even after an initial period of SCS, and aids decision-making regarding its instigation. Applying HMP in these situations has the potential to improve short-term patient outcomes. Furthermore, recognizing the opportunity to perfuse kidneys overnight and increasingly perform transplantation during daylight hours in an increasingly medically complex donor and recipient Odds ratios are from univariable binary logistic regression models within each subgroup, and are for HMP, relative to SCS. Bold P-values are significant at P < .05.
population offers potential financial, logistical, and patient safety benefits.
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